Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine

被引：39
|
作者：
Christie, S
Göbel, H
Mateos, V
Allen, C
Vrijens, F
Shivaprakash, M
机构：
[1] Merck & Co Inc, Dept WS3C 90, Whitehouse Stn, NJ 08889 USA
[2] Ottawa Headache Ctr, Ottawa, ON, Canada
[3] Univ Kiel, Kiel Pain Clin, Kiel, Germany
[4] Ctr Hosp Asturias, Dept Neurol, Oviedo, Spain
[5] Merck Sharp & Dohme Europe, Brussels, Belgium
来源：
EUROPEAN NEUROLOGY | 2003年 / 49卷 / 01期
关键词：
rizatriptan; ergotamine; efficacy; preference; migraine;
D O I：
10.1159/000067018
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：20 / 29
页数：10
相关论文
共 50 条
  • [31] Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis
    Goebel, Hartmut
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (04) : 499 - 506
  • [32] Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis
    Slof, J.
    Lainez, J. M.
    Comas, A.
    Heras, J.
    NEUROLOGIA, 2009, 24 (03): : 147 - 153
  • [33] COST-UTILITY ANALYSIS OF ORAL SUMATRIPTAN VERSUS ORAL ERGOTAMINE/CAFFEINE IN THE TREATMENT OF ACUTE MIGRAINE ATTACKS
    Ike, C.
    Devine, B.
    VALUE IN HEALTH, 2018, 21 : S207 - S207
  • [34] Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine
    Block, GA
    Goldstein, J
    Polis, A
    Reines, SA
    Smith, ME
    HEADACHE, 1998, 38 (10): : 764 - 771
  • [35] MULTICENTER, CROSSOVER STUDY OF THE EFFICACY AND TOLERABILITY OF TERFENADINE, 120 MG, VERSUS CETIRIZINE, 10 MG, IN PERENNIAL ALLERGIC RHINITIS
    RENTON, R
    FIDLER, C
    ROSENBERG, R
    ANNALS OF ALLERGY, 1991, 67 (04): : 416 - 420
  • [36] Patient-preference as primary endpoint in a randomised, double-blind, cross-over trial, comparing rizatriptan 10 mg and ibuprofen 400 mg for acute migraine treatment
    Dekker, F.
    Wiendels, N. J.
    Neven, A. Knuistingh
    Assendelft, W. J. J.
    Ferrari, M. D.
    CEPHALALGIA, 2011, 31 (01) : 17 - 18
  • [37] Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: A multicenter, randomized, crossover trial
    Di Monda, V
    Nicolodi, M
    Aloisio, A
    Del Bianco, P
    Fonzari, M
    Grazioli, I
    Uslenghi, C
    Vecchiet, L
    Sicuteri, F
    HEADACHE, 2003, 43 (08): : 835 - 844
  • [38] Improvement in health-related quality of life with rizatriptan 10mg compared with standard migraine therapy
    Gerth, WC
    Ruggles, KH
    Stark, SR
    Davies, GM
    Santanello, NC
    CLINICAL DRUG INVESTIGATION, 2001, 21 (12) : 853 - 860
  • [39] Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany
    Yoon, MS
    Katsarava, Z
    Liedert, B
    Krobot, KJ
    Diener, HC
    Limmroth, V
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (03) : 295 - 299
  • [40] Improvement in Health-Related Quality of Life with Rizatriptan 10mg Compared with Standard Migraine Therapy
    William C. Gerth
    Kevin H. Ruggles
    Stuart R. Stark
    Glenn M. Davies
    Nancy C. Santanello
    Clinical Drug Investigation, 2001, 21 : 853 - 860
12345